Related Experiment Video
Updated: Mar 26, 2026
08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
32.6K
Dopamine modulation of spatial navigation memory in Parkinson's disease
Franka Thurm1, Nicolas W Schuck2, Mareike Fauser3
1Chair of Lifespan Developmental Neuroscience, Department of Psychology, TU Dresden, Dresden, Germany.
Neurobiology of Aging
|February 2, 2016
Summary
Parkinson's disease patients rely on striatal cue-based learning, not hippocampal spatial memory. Dopamine medication improved striatal learning and, with experience, hippocampal learning in Parkinson's patients.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Movement Disorders
Background:
- Striatal dopamine depletion is central to Parkinson's disease (PD), affecting motor and nonmotor symptoms.
- Dopamine pathways also influence hippocampal function, impacting spatial memory, a less-studied area in PD.
- Previous research on nonmotor symptoms primarily focused on frontostriatal functions.
Purpose of the Study:
- To investigate how dopamine medication affects spatial memory in Parkinson's disease patients.
- To differentiate medication effects on striatal-dependent versus hippocampal-dependent spatial memory.
- To explore the relationship between medication effects on cognitive and motor symptoms in PD.
Main Methods:
- A virtual spatial navigation task was employed in a crossover medication ON/OFF design.
- Two types of spatial memory tasks were used: cue-location replacement (striatal) and boundary enlargement (hippocampal).
- Participants included Parkinson's disease patients and age-matched controls.
Main Results:
- Parkinson's disease patients, similar to controls, showed a greater reliance on striatal cue-based learning over hippocampal spatial learning.
- Medication significantly enhanced striatal-dependent cue-location learning.
- Medication benefits for hippocampal boundary-related memory were contingent on prior task experience.
- Cognitive benefits from medication were comparable to and independent of motor symptom improvements.
Conclusions:
- Parkinson's disease patients exhibit a distinct pattern of spatial memory reliance, favoring striatal over hippocampal strategies.
- Dopaminergic medication differentially modulates striatal and hippocampal spatial memory systems in PD.
- These findings highlight the complex role of dopamine in hippocampal-striatal interactions and spatial cognition in Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
01:37Neural Regulation
44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K